What Are The Concerns About Covaxin’s Approval for Emergency Use?

What Are The Concerns About Covaxin’s Approval for Emergency Use?

0 평가
0
Episode
158 of 511
길이
14분
언어
영어
형식
카테고리
논픽션

The new year has begun with a significant event in India's long fight against COVID-19. On 3 January, Covishield and Covaxin became the first Coronavirus vaccines in the country to get emergency approval by the DCGI.

Covishield, as we know, is Oxford-AstraZeneca’s vaccine candidate being manufactured by the Serum Institute in India. But it is the conditional approval of Covaxin — India's swadeshi vaccine candidate that is raising some questions and controversies.

Well firstly, Covaxin is still in its Phase III trials which triggered concerns of safety. And unlike the other vaccines that have received emergency authorisation worldwide, we don't exactly know its level of efficacy right now, which can only be determined after it has gone through large scale phase III trials.

While experts are pointing out some of the gaps in this decision for emergency authorization, an infuriated Dr Krishna Ella, the MD of Bharat Biotech responded to the criticism saying that their method has been transparent and that this vaccine is in no way inferior to the international ones.

So what is it that do we know about Covaxin so far? How does this vaccine work? What are the concerns being raised by experts? And how is the vaccination drive going to be implemented if it's yet to conclude its trials? Tune in to The Big Story!

Producer and Host: Shorbori Purkayastha Guest: Dr Randeep Guleria, Director of AIIMS, Dr Anant Bhan, Adjunct Professor & Researcher in Bioethics at Mangaluru’s Yenepoya University Interviews: Vaishali Sood, Devina Buckshee

Editor: Shelly Walia

Music: Big Bang Fuzz

Listen to The Big Story podcast on:

Apple: https://apple.co/2AYdLIl

Saavn: http://bit.ly/2oix78C

Google Podcasts: http://bit.ly/2ntMV7S

Spotify: https://spoti.fi/2IyLAUQ

Deezer: http://bit.ly/2Vrf5Ng Learn more about your ad choices. Visit megaphone.fm/adchoices


듣고 읽기

무한한 이야기의 세계로 들어가 보세요

  • 원하는 만큼 읽고 듣기
  • 100만 개 이상의 타이틀
  • 스토리텔 독점 + 스토리텔 오리지널
  • 14일 무료 체험 후 월 €9.99
  • 언제든 손쉽게 구독해지 가능
지금 바로 시작해보세요!
kr all devices
Cover for What Are The Concerns About Covaxin’s Approval for Emergency Use?

당신이 좋아할 만한 다른 팟캐스트...